There is no FDA-specified waiting period before restarting ketorolac after a completed 5-day course. The FDA label strictly limits each course to a combined maximum of 5 days (oral and injectable together) but does not define how long you need to wait before beginning another round. In practice, most prescribers allow a gap of at least one to two weeks before considering another short course, though the decision depends heavily on your individual risk factors.
Why Ketorolac Has a 5-Day Limit
Ketorolac is one of the strongest prescription-strength anti-inflammatory painkillers available, and that potency is exactly why it carries a strict time cap. The FDA’s black box warning states that the total combined duration of oral and injectable ketorolac must not exceed 5 days, because the frequency and severity of adverse reactions climb sharply with longer use. The two biggest concerns are gastrointestinal bleeding and kidney damage, both of which become more likely the longer a course continues.
The drug has a relatively short elimination half-life of 4 to 6 hours, meaning it clears from your bloodstream within about a day after your last dose. But its effects on your stomach lining and kidneys can linger beyond that window. Repeated exposure without adequate recovery time compounds those risks rather than simply resetting them.
What “Restarting” Actually Looks Like in Practice
Because the FDA label doesn’t spell out a mandatory washout period, there’s no universal protocol. What clinicians typically weigh is whether the tissues most vulnerable to ketorolac, your stomach lining and kidneys, have had enough time to recover. A gap of one to two weeks is a common minimum before a second 5-day course is considered, but some providers prefer longer intervals, particularly for patients with any kidney concerns or a history of stomach ulcers.
A population-based study published in PLOS One found that ketorolac carried roughly a 2.5-fold increased risk of chronic kidney disease even with short-term use. The researchers noted that this high-potency painkiller could push borderline kidney function into clinically significant territory. That finding is one reason many clinicians are cautious about repeated cycles and prefer to use ketorolac as sparingly as possible rather than treating it as something to rotate on and off.
Factors That Affect Your Timeline
Not everyone faces the same level of risk with a second course. Several factors will influence how soon, or whether, your prescriber is comfortable restarting ketorolac:
- Kidney function. If your kidneys are already working harder than normal due to age, dehydration, diabetes, or other medications, the drug puts more strain on them and recovery takes longer.
- Age. Adults over 65 clear ketorolac more slowly and are more susceptible to both GI bleeding and kidney injury. Providers often prefer alternatives in this group.
- GI history. A history of ulcers, gastritis, or GI bleeding raises the stakes considerably. Even a single 5-day course can irritate the stomach lining enough to cause problems in susceptible people.
- Other medications. Blood thinners, other anti-inflammatory drugs, corticosteroids, and certain blood pressure medications all interact with ketorolac and can amplify its side effects.
Alternatives After the 5-Day Window
If your pain persists beyond one course of ketorolac, switching to a different anti-inflammatory is the most common next step. Ibuprofen and naproxen do not carry the same 5-day FDA limit, though they share the same general class of risks at a lower intensity. Some pain specialists recommend capping any anti-inflammatory at roughly 5 days for acute pain episodes regardless of the specific drug, reassessing the pain at that point rather than simply continuing.
Combining a milder anti-inflammatory with acetaminophen, ice, elevation, or other non-drug strategies can often match ketorolac’s effectiveness for many types of post-surgical or injury-related pain. This multimodal approach reduces the need for repeated ketorolac courses in the first place.
Signs You Should Not Restart
Before beginning a second course, pay attention to how your body responded to the first one. Dark or tarry stools, stomach pain, nausea, blood in your urine, decreased urine output, unusual swelling, or unexplained fatigue can all signal that ketorolac stressed your GI tract or kidneys more than expected. Any of these symptoms after a completed course is a reason to choose a different pain management approach rather than restarting the same drug.